Young people who inject drugs in Mozambique: should we emphasize them in the National Harm Reduction Plan?


Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
26 03 2020
Historique:
received: 13 08 2019
accepted: 13 03 2020
entrez: 29 3 2020
pubmed: 29 3 2020
medline: 7 7 2021
Statut: epublish

Résumé

Mozambique has one of the highest burdens of HIV globally, and people who inject drugs (PWID) have one of the highest HIV infection rates in Africa. After the implementation of the first Biological Behavioral Surveillance (BBS) Survey among PWID in Mozambique, the Ministry of Health started the development of a National Harm Reduction Plan. Although the findings from the BBS survey highlighted the specific needs of young PWID, the proposed Harm Reduction Plan does not explicitly focus on reducing high-risk behaviors of young PWID. We outline the importance of the inclusion of age-specific interventions focused on the needs of young PWID in Mozambique, and how a comprehensive Harm Reduction Plan can reduce the HIV epidemic in this population. There is a unique opportunity to advocate for the Harm Reduction Plan to include "youth-friendly" cost-effective and evidence-based interventions that are targeted to this important sub-group within an already vulnerable population.

Identifiants

pubmed: 32216809
doi: 10.1186/s12954-020-00363-6
pii: 10.1186/s12954-020-00363-6
pmc: PMC7098094
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

20

Références

Lancet Psychiatry. 2016 Mar;3(3):280-96
pubmed: 26905481
Int J Drug Policy. 2018 Jul;57:111-118
pubmed: 29730586
Harm Reduct J. 2017 Jul 31;14(1):53
pubmed: 28760146
BMC Infect Dis. 2019 Dec 2;19(1):1022
pubmed: 31791273
J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19442
pubmed: 25724510
Paediatr Child Health. 2008 Jan;13(1):53-60
pubmed: 19119355
PLoS One. 2013 Jun 25;8(6):e67062
pubmed: 23825620
J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19833
pubmed: 25724511
J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19438
pubmed: 25724509
Lancet HIV. 2016 Jul;3(7):e323-32
pubmed: 27365207
Int J Drug Policy. 2016 Apr;30:140-2
pubmed: 27017377
Open AIDS J. 2016 Apr 08;10:34-48
pubmed: 27347270
Lancet. 2010 Aug 14;376(9740):551-63
pubmed: 20650515
J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S144-53
pubmed: 24918590
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207
pubmed: 29074409
BMC Health Serv Res. 2014 Jun 16;14:259
pubmed: 24934095

Auteurs

Cynthia Semá Baltazar (C)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique. cynthiasema@yahoo.com.
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. cynthiasema@yahoo.com.

Makini Boothe (M)

Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Timothy Kellogg (T)

University of California, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH